[PLX] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
18-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 162.92%
YoY- 164.60%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 14,248 12,247 10,439 27,018 663 2,006 4,553 113.79%
PBT -3,560 -7,743 -7,264 9,781 -15,544 -11,294 -9,400 -47.62%
Tax 34 3 190 99 230 75 132 -59.48%
NP -3,560 -7,743 -7,264 9,781 -15,544 -11,294 -9,400 -47.62%
Tax Rate - - - -1.01% - - - -
Total Cost 17,808 19,990 17,703 17,237 16,207 13,300 13,953 17.64%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -24.99 -63.22 -69.59 36.20 -2,344.49 -563.01 -206.46 -75.49%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -0.24 -0.52 -0.49 0.66 -1.05 -0.77 -0.65 -48.50%
EPS Diluted -0.24 -0.52 -0.49 0.66 -1.05 -0.77 -0.65 -48.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.